Liquidia (LQDA) rebounds after YUTREPIA FDA approval and $51.7M sales, but inventory effects, demand uncertainty, and patent ...

Caplacizumab is a von Willebrand factor (vWF)-directed antibody fragment designed to inhibit the interaction between vWF and platelets.

NDPS Act cases topped all crime categories in Mohali during 2025, followed by street crimes like vehicle theft and snatching ...

Transaction expands ADDMAN's polymer 3d printing production capabilities and digital infrastructure.FORT MYERS, Fla., Jan. 5, 2026 /PRNewswire/ -- ADDMAN ...

Injection molding equipment maker invests RMB 5 billion in new Foshan facility integrating R&D manufacturing and services ...

This decision follows the actions of other major manufacturers, who have either significantly scaled back their operations in ...